TLR2 and candidiasis: Given the marked effect of extended TLR2 agonist treatment on the phenotype of ex vivo produced macrophages, as well as on the accumulation of HSPCs and mature myeloid cells in the spleen, we next addressed the possibility that this treatment could influence the in vivo susceptibility to invasive candidiasis.